Ahmad B. Tarabishy, MD » Hydroxychloroquine Maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy

Jul 23 2023 by Ahmad B. Tarabishy, MD

62 year old female with rheumatoid arthritis, treated with hydroxychloroquine 200 mg BID for the past 6-8 years. She presents with blurred vision, difficulty reading, and difficulty transitions from dark to light conditions since 4 months.

Photographer: Dr. Angela Rico

Condition/keywords: hydroxychloroquine toxicity, plaquenil toxicity, toxic maculopathy